413 related articles for article (PubMed ID: 11081315)
1. [Clinical evaluation of a dual chamber implantable cardioverter-defibrillator].
Kazmierczak J; Tavernier R; De Sutter J; Jordaens L
Pol Merkur Lekarski; 2000 Aug; 9(50):522-6. PubMed ID: 11081315
[TBL] [Abstract][Full Text] [Related]
2. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
[TBL] [Abstract][Full Text] [Related]
3. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.
Proclemer A; Della Bella P; Facchin D; Fattore L; Carbucicchio C; Tondo C; Lunati M; Vecchi MR; Petz E; Zecchin M
Europace; 2001 Apr; 3(2):132-5. PubMed ID: 11333050
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator.
Sinha AM; Stellbrink C; Schuchert A; Mox B; Jordaens L; Lamaison D; Gill J; Kaplan A; Merkely B;
J Cardiovasc Electrophysiol; 2004 Jun; 15(6):646-52. PubMed ID: 15175058
[TBL] [Abstract][Full Text] [Related]
5. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
[TBL] [Abstract][Full Text] [Related]
6. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
[TBL] [Abstract][Full Text] [Related]
7. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
8. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
[TBL] [Abstract][Full Text] [Related]
9. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
[TBL] [Abstract][Full Text] [Related]
11. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
12. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms.
Theuns DA; Klootwijk AP; Goedhart DM; Jordaens LJ
J Am Coll Cardiol; 2004 Dec; 44(12):2362-7. PubMed ID: 15607399
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with tiered atrial therapies and atrial arrhythmia prevention algorithms in a dual chamber cardioverter defibrillator.
Daoud EG; Nademanee K; Fuenzalida C; Tomassoni GF; Schuger C; Chisner M; Simones M; Schwartz M; Reeve H
J Cardiovasc Electrophysiol; 2006 Aug; 17(8):852-6. PubMed ID: 16903964
[TBL] [Abstract][Full Text] [Related]
14. Role of implantable cardioverter defibrillator therapy in the management of high-risk patients.
Akhtar M; Avitall B; Jazayeri M; Tchou P; Troup P; Sra J; Axtell K
Circulation; 1992 Jan; 85(1 Suppl):I131-9. PubMed ID: 1728496
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.
Brigadeau F; Kouakam C; Klug D; Marquié C; Duhamel A; Mizon-Gérard F; Lacroix D; Kacet S
Eur Heart J; 2006 Mar; 27(6):700-7. PubMed ID: 16421175
[TBL] [Abstract][Full Text] [Related]
16. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia.
Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S
Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696
[TBL] [Abstract][Full Text] [Related]
17. An overview of the fifth-generation implantable cardioverter defibrillator.
Tanaka S
Ann Thorac Cardiovasc Surg; 1998 Dec; 4(6):303-11. PubMed ID: 9914457
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with a second-generation cardioverter-defibrillator].
Meyer BJ; Candinas R; Gloor HO; Bertel O; Amann FW; Turina MI
Schweiz Med Wochenschr; 1991 Nov; 121(46):1701-5. PubMed ID: 1957143
[TBL] [Abstract][Full Text] [Related]
19. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
[TBL] [Abstract][Full Text] [Related]
20. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
